NEXENTIS TECHNOLOGIES INC. Long-Lived Assets
NEXENTIS TECHNOLOGIES INC. (NXTS) had Long-Lived Assets of $5.19 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2026-03-31
- 2025-12-31: Long-Lived Assets $5.19M.
- 2024-12-31: Long-Lived Assets $8.00K; Long-Lived Assets as first filed $56.00K.
- 2024-09-30: Long-Lived Assets $68.64K.
- 2024-06-30: Long-Lived Assets $84.86K.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2025-12-31 | $5.19M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $8.00K 10-K · filed 2026-03-31 | $56.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $68.64K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $84.86K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $104.20K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $123.00K 10-K · filed 2025-03-31 | $123.15K 10-Q · filed 2024-08-14 |
| 2023-03-31 | $191.21K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |